Evidence map›Paper›PMID 42791560›Full record

ArticleMolecular neurodegeneration2026

Dynamic [

Johannes Gnörich, Julia Kusche-Palenga, Agnes Kling, Amir Dehsarvi, Angela Bronte, Lukas Frontzkowski, Artem Zatcepin, Mirlind Zaganjori, Florian Schöberl, Sebastian N Roemer-Cassiano and 25 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular neurodegeneration, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Johannes GnörichDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Julia Kusche-PalengaDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Agnes KlingDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Amir DehsarviInstitute for Stroke and Dementia Research, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Angela BronteUniversidad de Navarra, Pamplona, Spain.
Lukas FrontzkowskiDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Artem ZatcepinDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Mirlind ZaganjoriDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Florian SchöberlDepartment of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Sebastian N Roemer-CassianoInstitute for Stroke and Dementia Research, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Boris-Stephan RauchmannDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Carolin KurzDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Carla PalleisGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Alexander M BernhardtGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Alexander JäckGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Sabrina KatzdoblerGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Maximilian ScheifeleDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Theresa BauerDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Gérard N BischofDepartment of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Thilo van EimerenDepartment of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Alexander DrzezgaDepartment of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Jan HäckertDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Robert PerneczkyGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Michael RullmannDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Katharina BuergerInstitute for Stroke and Dementia Research, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Rudolf A WernerDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Andreas ZwergalDepartment of Neurology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Johannes LevinGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Osama SabriDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Henryk BarthelDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Sophia StöckleinDepartment of Radiology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Günter HöglingerGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Nicolai FranzmeierInstitute for Stroke and Dementia Research, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany. Matthias.Brendel@med.uni-muenchen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with Alzheimer's disease (AD) and clinically overlapping neurodegenerative diseases are classified molecularly using the A/T/N classification system. Apart from fluid biomarkers and structural MRI, A/T/N assessment incorporates β-amyloid-PET (A), tau-PET (T), and [

methodsWe studied 129 patients with tauopathies, comprising 47 patients with β-amyloid-positive 3/4-repeat tauopathy and 82 patients with β-amyloid-negative primary 4-repeat tauopathies, alongside 17 healthy controls. Participants underwent 60-minute dynamic [

results[

conclusionsDynamic [

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesNeurodegenerative DiseasesTauopathiestau ProteinsAgedBiomarkersBrainFemaleFluorine RadioisotopesHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographyPyridines((18)F)PI-2620Amyloid beta-PeptidesBiomarkersFluorine RadioisotopesPI-2620Pyridinestau ProteinsA/T/NDynamic imagingStagingTauopathiesTau-PETβ-amyloid

Identifiers

PMID42791560
PMCPMC13615581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.